Treatment targets in these patients is almost exclusively directed against the immune response and there are now several treatment alternatives available all with their advantages and disadvantages. Important for a good treatment (stated from our web survey) is:
- According to patients: Quality of life
- According to physicians: protection against long-term disability
- None of these are very well reflected in standard two year randomized clinical trials.
Treatments used in MS
|Generic name||Brand name|
|Interferon beta (IFNβ)||Avonex, Betaferon, Extavia, Rebif, Plegridy|
|Glatiramer acetate (GA)||Copaxone|
To find detailed description of mode of actions, doses and side effects, please visit the Medical Products Agency or the Swedish MS society and patient organizations.